Charles River Laboratories International Competitors

Charles River Laboratories International (CNSX:CRL) and Akumin (TSE:AKU) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, earnings, profitability and institutional ownership.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Charles River Laboratories International and Akumin, as reported by MarketBeat.

Akumin has a consensus target price of C$4.25, suggesting a potential upside of 8.70%.

Profitability

This table compares Charles River Laboratories International and Akumin's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Charles River Laboratories International and Akumin's top-line revenue, earnings per share and valuation.

Charles River Laboratories International has higher earnings, but lower revenue than Akumin.

Summary

Akumin beats Charles River Laboratories International on 2 of the 2 factors compared between the two stocks.

Charles River Laboratories International (CNSX:CRL) and LexaGene (CVE:LXG) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, analyst recommendations, dividends, institutional ownership and profitability.

Analyst Ratings

This is a breakdown of current ratings and target prices for Charles River Laboratories International and LexaGene, as provided by MarketBeat.com.

Profitability

This table compares Charles River Laboratories International and LexaGene's net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Charles River Laboratories International and LexaGene's gross revenue, earnings per share and valuation.

Charles River Laboratories International (CNSX:CRL) and SQI Diagnostics (CVE:SQD) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk.

Valuation & Earnings

This table compares Charles River Laboratories International and SQI Diagnostics' revenue, earnings per share and valuation.

Charles River Laboratories International has higher earnings, but lower revenue than SQI Diagnostics.

Profitability

This table compares Charles River Laboratories International and SQI Diagnostics' net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Charles River Laboratories International and SQI Diagnostics, as provided by MarketBeat.

Summary

SQI Diagnostics beats Charles River Laboratories International on 1 of the 1 factors compared between the two stocks.

Sernova (CVE:SVA) and Charles River Laboratories International (CNSX:CRL) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, profitability and valuation.

Profitability

This table compares Sernova and Charles River Laboratories International's net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of recent ratings and price targets for Sernova and Charles River Laboratories International, as reported by MarketBeat.

Valuation & Earnings

This table compares Sernova and Charles River Laboratories International's gross revenue, earnings per share and valuation.

Charles River Laboratories International (CNSX:CRL) and GeneNews (TSE:GEN) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, risk, analyst recommendations and earnings.

Profitability

This table compares Charles River Laboratories International and GeneNews' net margins, return on equity and return on assets.

Valuation & Earnings

This table compares Charles River Laboratories International and GeneNews' revenue, earnings per share and valuation.

Charles River Laboratories International has higher earnings, but lower revenue than GeneNews.

Analyst Recommendations

This is a breakdown of current ratings for Charles River Laboratories International and GeneNews, as provided by MarketBeat.

Summary

GeneNews beats Charles River Laboratories International on 1 of the 1 factors compared between the two stocks.

Charles River Laboratories International (CNSX:CRL) and LED Medical Diagnostics (CVE:LMD) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, dividends, analyst recommendations, valuation and earnings.

Analyst Ratings

This is a breakdown of current recommendations and price targets for Charles River Laboratories International and LED Medical Diagnostics, as provided by MarketBeat.

Profitability

This table compares Charles River Laboratories International and LED Medical Diagnostics' net margins, return on equity and return on assets.

Valuation and Earnings

This table compares Charles River Laboratories International and LED Medical Diagnostics' revenue, earnings per share and valuation.

Charles River Laboratories International has higher earnings, but lower revenue than LED Medical Diagnostics.

Summary

LED Medical Diagnostics beats Charles River Laboratories International on 1 of the 1 factors compared between the two stocks.